NO20045497L - Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater - Google Patents

Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater

Info

Publication number
NO20045497L
NO20045497L NO20045497A NO20045497A NO20045497L NO 20045497 L NO20045497 L NO 20045497L NO 20045497 A NO20045497 A NO 20045497A NO 20045497 A NO20045497 A NO 20045497A NO 20045497 L NO20045497 L NO 20045497L
Authority
NO
Norway
Prior art keywords
sub
oxazol
preparation
benzoic acid
acid derivatives
Prior art date
Application number
NO20045497A
Other languages
English (en)
Norwegian (no)
Other versions
NO20045497D0 (no
Inventor
Michael R Reeder
Rick J Imbordino
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of NO20045497D0 publication Critical patent/NO20045497D0/no
Publication of NO20045497L publication Critical patent/NO20045497L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
NO20045497A 2002-06-20 2004-12-16 Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater NO20045497L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US45047803P 2003-02-27 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (2)

Publication Number Publication Date
NO20045497D0 NO20045497D0 (no) 2004-12-16
NO20045497L true NO20045497L (no) 2005-03-07

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045497A NO20045497L (no) 2002-06-20 2004-12-16 Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater

Country Status (17)

Country Link
US (2) US7115747B2 (de)
EP (1) EP1532123B1 (de)
JP (1) JP2005533811A (de)
CN (1) CN1324017C (de)
AT (1) ATE370131T1 (de)
AU (1) AU2003249344A1 (de)
BR (1) BR0312439A (de)
CA (1) CA2489988A1 (de)
CO (1) CO5670350A2 (de)
DE (1) DE60315664D1 (de)
EA (1) EA008389B1 (de)
IL (1) IL165763A0 (de)
MX (1) MXPA04012630A (de)
NO (1) NO20045497L (de)
NZ (1) NZ537390A (de)
PL (1) PL374999A1 (de)
WO (1) WO2004000821A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004050609A1 (en) * 2002-11-27 2004-06-17 Elan Pharmaceutical, Inc. Substituted ureas and carbamates
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
JP5274258B2 (ja) 2005-11-21 2013-08-28 アムジエン・インコーポレーテツド β−セクレターゼ調節物質及び使用方法
US7838676B2 (en) 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) * 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) * 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
WO2008137954A2 (en) * 2007-05-07 2008-11-13 Environmental Packaging Technologies Limited Universal shipping container
EP2167471B1 (de) * 2007-05-25 2013-10-16 Amgen Inc. Substituierte hydroxyethylaminverbindungen als modulatoren von beta-sekretase und anwendungsverfahren
WO2008147547A1 (en) 2007-05-25 2008-12-04 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
US8426447B2 (en) 2008-09-11 2013-04-23 Amgen Inc. Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use
EP2504330A1 (de) 2009-11-23 2012-10-03 Amgen Inc. Aminoheteroarylverbindungen als beta-sekretase-modulatoren und verwendungsverfahren dafür
EP2504315A1 (de) 2009-11-23 2012-10-03 Amgen Inc. Aminoheteroarylverbindungen als beta-sekretase-modulatoren und verwendungsverfahren dafür
CA2788363A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
JP5584352B2 (ja) 2010-03-15 2014-09-03 アムジエン・インコーポレーテツド β−セクレターゼ調節剤としてのアミノ−ジヒドロオキサジン系およびアミノ−ジヒドロチアジン系スピロ化合物ならびにそれらの医学的用途
US8883782B2 (en) 2010-03-15 2014-11-11 Amgen Inc. Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
US9346827B2 (en) 2011-02-07 2016-05-24 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
JP2014526560A (ja) 2011-09-21 2014-10-06 アムジエン・インコーポレーテツド β‐セクレターゼ調節因子としてのアミノオキサジン化合物およびアミノジヒドロチアジン化合物および使用方法
WO2014078314A1 (en) 2012-11-15 2014-05-22 Amgen Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020276A1 (es) * 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
BR0213139A (pt) 2001-10-04 2004-08-10 Elan Pharm Inc Composto, método de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto e composição farmacêutica
EP1453789A2 (de) * 2001-11-08 2004-09-08 Elan Pharmaceuticals, Inc. N,n'-substituierte 1,3-diamino-2-hydroxypropanderivate
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EP1532123A1 (de) 2005-05-25
US7115747B2 (en) 2006-10-03
AU2003249344A1 (en) 2004-01-06
ATE370131T1 (de) 2007-09-15
US20040063965A1 (en) 2004-04-01
MXPA04012630A (es) 2005-09-30
EA200401510A1 (ru) 2005-06-30
EP1532123B1 (de) 2007-08-15
DE60315664D1 (de) 2007-09-27
JP2005533811A (ja) 2005-11-10
CO5670350A2 (es) 2006-08-31
EA008389B1 (ru) 2007-04-27
US20070105921A1 (en) 2007-05-10
BR0312439A (pt) 2005-05-10
CN1662510A (zh) 2005-08-31
HK1081543A1 (zh) 2006-05-19
NO20045497D0 (no) 2004-12-16
IL165763A0 (en) 2006-01-15
CA2489988A1 (en) 2003-12-31
CN1324017C (zh) 2007-07-04
PL374999A1 (en) 2005-11-14
WO2004000821A1 (en) 2003-12-31
NZ537390A (en) 2006-07-28

Similar Documents

Publication Publication Date Title
NO20045497L (no) Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater
EA200500006A1 (ru) Лекарственное средство для лечения нейродегенеративных заболеваний
WO2004094384A3 (en) (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
EA200101194A1 (ru) Производные 4,5,6,7-тетрагидроиндазола в качестве противоопухолевых средств
MY142768A (en) Gfat inhibitors
ATE354562T1 (de) Cyclohexylsulfon-derivate als gamma-secretase- inhibitoren
EA200501820A1 (ru) Терапевтические средства для лечения боли
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
EA200401114A2 (ru) Замещённые гидроксиэтиламины
DE50304030D1 (de) Verfahren zur Herstellung von 5-Nitrobenzofuranen
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
ATE374773T1 (de) Polycyclische verbindungen als potenten alpha2- adrenoceptor antagonisten
DE602004011255D1 (de) Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
RU2004126861A (ru) Производные пиридинамидов в качестве ингибиторов моноаминоксидазы (мао-в)
JP2007507467A5 (de)
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
NO20033049D0 (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1
NO20054418L (no) Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse
WO2004067505A3 (en) Bismuth dithiocarbamate compounds and uses thereof
TW200637856A (en) Process for producing thiazolidinedion compound and intermediate thereof
WO2004032854A3 (en) Pharmaceutical compositions for treatment of parkinson's disease
PE20010216A1 (es) Procedimiento para preparar derivados de 10,11-metanobenzosuberano

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application